These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 2670633
1. Comparison of two oral forms of erythromycin in the treatment of acute respiratory tract infections. A multicentre general practice study. Macklin J, Barden R, Coles S. J Int Med Res; 1989; 17(3):287-94. PubMed ID: 2670633 [Abstract] [Full Text] [Related]
2. Comparison of oral erythromycin ethylsuccinate and ciprofloxacin in the treatment of acute respiratory tract infections. Feld MS, Carnegie C, Macklin J, Coles S. Br J Clin Pract; 1990 Oct; 44(10):404-8. PubMed ID: 2268518 [Abstract] [Full Text] [Related]
3. Comparison of oral erythromycin ethylsuccinate and clavulanate-potentiated amoxicillin in the treatment of acute respiratory tract infections. Shanks N, Macklin J, Coles S. Clin Ther; 1989 Oct; 11(6):812-9. PubMed ID: 2692823 [Abstract] [Full Text] [Related]
4. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections]. Bertrand A, Jonquet O, Sauvaget J. Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354 [Abstract] [Full Text] [Related]
5. Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability. Saloranta P, Roos L, Elonen E, Allonen H. J Antimicrob Chemother; 1989 Sep; 24(3):455-62. PubMed ID: 2808197 [Abstract] [Full Text] [Related]
6. Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base. Wuolijoki E, Flygare U, Hildén M, Hurme J, Järvinen H, Leskinen J, Pynnönen S, Riikonen A, Salomaa V, Seuri M. J Antimicrob Chemother; 1988 Jun; 21 Suppl D():107-12. PubMed ID: 3391872 [Abstract] [Full Text] [Related]
7. Comparison of spiramycin with erythromycin for lower respiratory tract infections. De Cock L, Poels R. J Antimicrob Chemother; 1988 Jul; 22 Suppl B():159-63. PubMed ID: 3053570 [Abstract] [Full Text] [Related]
11. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses. Yakatan GJ, Rasmussen CE, Feis PJ, Wallen S. J Clin Pharmacol; 1985 Jul; 25(1):36-42. PubMed ID: 3871797 [Abstract] [Full Text] [Related]
12. Tolerance and efficacy of erythromycin stearate tablets versus enteric-coated erythromycin base capsules in the treatment of patients with acne vulgaris. Bleeker J. J Int Med Res; 1983 Jul; 11(1):38-41. PubMed ID: 6219902 [Abstract] [Full Text] [Related]
14. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin. Tjandramaga TB, Van Hecken A, Mullie A, Verbesselt R, De Schepper PJ, Verbist L, Josefsson K. Pharmacology; 1984 Jul; 29(6):305-11. PubMed ID: 6334320 [Abstract] [Full Text] [Related]
16. Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts. Gordin A, Salmi HA, Antikainen R. J Antimicrob Chemother; 1988 Jun; 21 Suppl D():93-9. PubMed ID: 3391881 [Abstract] [Full Text] [Related]
17. Efficacy and tolerance of enteric-coated erythromycin base (Ery-Max) administered twice or four times daily in patients with acute bronchitis. Pekkanen PS, Josefsson K. J Int Med Res; 1983 Jun; 11(5):285-8. PubMed ID: 6642069 [Abstract] [Full Text] [Related]
18. Clinical and pharmacological evaluation of different preparations of oral erythromycin. Butzler JP, Vanhoof R, Clumeck N, de Mol P, Vanderlinden MP, Yourassowsky E. Chemotherapy; 1979 Jun; 25(6):367-72. PubMed ID: 316377 [Abstract] [Full Text] [Related]